Elevation Point Wealth Partners LLC Makes New $525,000 Investment in Mettler-Toledo International, Inc. $MTD

Elevation Point Wealth Partners LLC bought a new position in Mettler-Toledo International, Inc. (NYSE:MTD) in the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor bought 416 shares of the medical instruments supplier’s stock, valued at approximately $525,000.

A number of other institutional investors and hedge funds also recently made changes to their positions in MTD. Geneos Wealth Management Inc. grew its position in shares of Mettler-Toledo International by 83.3% in the 1st quarter. Geneos Wealth Management Inc. now owns 66 shares of the medical instruments supplier’s stock worth $78,000 after buying an additional 30 shares during the period. Baird Financial Group Inc. boosted its stake in Mettler-Toledo International by 3.1% during the second quarter. Baird Financial Group Inc. now owns 1,347 shares of the medical instruments supplier’s stock worth $1,582,000 after acquiring an additional 40 shares in the last quarter. Jump Financial LLC grew its holdings in Mettler-Toledo International by 44.6% in the second quarter. Jump Financial LLC now owns 405 shares of the medical instruments supplier’s stock worth $476,000 after purchasing an additional 125 shares during the period. Cerity Partners LLC grew its holdings in Mettler-Toledo International by 10.8% in the second quarter. Cerity Partners LLC now owns 4,035 shares of the medical instruments supplier’s stock worth $4,740,000 after purchasing an additional 392 shares during the period. Finally, AXA S.A. increased its stake in shares of Mettler-Toledo International by 2.9% during the second quarter. AXA S.A. now owns 4,625 shares of the medical instruments supplier’s stock valued at $5,433,000 after purchasing an additional 131 shares in the last quarter. Hedge funds and other institutional investors own 95.07% of the company’s stock.

Analysts Set New Price Targets

MTD has been the subject of a number of analyst reports. Wolfe Research started coverage on Mettler-Toledo International in a research report on Tuesday, June 2nd. They set a “peer perform” rating for the company. Citigroup lowered their price target on Mettler-Toledo International from $1,700.00 to $1,550.00 and set a “buy” rating for the company in a research report on Friday, May 8th. Barclays dropped their price target on shares of Mettler-Toledo International from $1,550.00 to $1,500.00 and set an “overweight” rating on the stock in a research note on Tuesday, April 14th. Jefferies Financial Group raised shares of Mettler-Toledo International from a “hold” rating to a “buy” rating and raised their price target for the company from $1,400.00 to $1,450.00 in a research report on Friday, March 20th. Finally, Stifel Nicolaus decreased their price objective on shares of Mettler-Toledo International from $1,600.00 to $1,400.00 and set a “buy” rating for the company in a report on Monday, May 18th. Six research analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the stock. According to MarketBeat, Mettler-Toledo International presently has an average rating of “Hold” and an average target price of $1,408.55.

Mettler-Toledo International Stock Down 3.6%

Shares of NYSE MTD opened at $1,249.12 on Thursday. The firm’s 50-day moving average price is $1,175.86 and its 200-day moving average price is $1,287.00. The company has a market cap of $25.24 billion, a PE ratio of 29.29, a PEG ratio of 2.70 and a beta of 1.24. Mettler-Toledo International, Inc. has a 52-week low of $1,023.05 and a 52-week high of $1,525.17.

Mettler-Toledo International (NYSE:MTD) last released its quarterly earnings data on Thursday, May 7th. The medical instruments supplier reported $8.91 earnings per share for the quarter, beating the consensus estimate of $8.70 by $0.21. Mettler-Toledo International had a net margin of 21.40% and a negative return on equity of 622.80%. The firm had revenue of $947.13 million during the quarter, compared to analysts’ expectations of $943.14 million. During the same period in the previous year, the company earned $8.19 earnings per share. The firm’s quarterly revenue was up 7.2% on a year-over-year basis. Mettler-Toledo International has set its FY 2026 guidance at 46.300-46.950 EPS and its Q2 2026 guidance at 10.700-10.850 EPS. As a group, equities research analysts anticipate that Mettler-Toledo International, Inc. will post 46.6 EPS for the current fiscal year.

Mettler-Toledo International Profile

Mettler-Toledo International Inc is a global manufacturer and distributor of precision instruments and services for laboratory, industrial and food retail applications. The company’s product portfolio includes laboratory balances and analytical instruments, industrial weighing systems, process analytics and sensors, metal detection and x-ray inspection equipment, checkweighers, and a range of automated inspection and data-management solutions. Mettler-Toledo also provides software, calibration and lifecycle services intended to support compliance, quality control and operational efficiency across customer facilities.

The company serves a broad set of end markets including pharmaceutical and biotech laboratories, chemical and food processors, logistics and manufacturing operations, and retail environments where accurate weighing and inspection are critical.